Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FYX20
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,842
Award facts
- Contract value 100% obligated
- $12,841.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,841.65 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for the supply of Xolair 150 mg/mL auto-injector medication. The contract, which must be completed by August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery order represents a single transactional purchase under the broader pharmaceutical supply relationship between the company and the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026. The IDC enables the agency to procure an extensive portfolio of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide, spanning prescription medications, biologics, auto-injectors, and specialty pharmaceuticals. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple contract awards for delivering branded and generic medications and medical consumables to military health systems.
Quick answers
Who was awarded contract SPE2DB25FYX20?
SPE2DB25FYX20 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FYX20 worth?
The government has obligated $12,842 on SPE2DB25FYX20.
Is contract SPE2DB25FYX20 an order under another contract?
Yes. SPE2DB25FYX20 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX20 competed?
The extent of competition for SPE2DB25FYX20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award